WO1998023156A1 - Fongicides et arthropodicides a substitution methyle - Google Patents

Fongicides et arthropodicides a substitution methyle Download PDF

Info

Publication number
WO1998023156A1
WO1998023156A1 PCT/US1997/021944 US9721944W WO9823156A1 WO 1998023156 A1 WO1998023156 A1 WO 1998023156A1 US 9721944 W US9721944 W US 9721944W WO 9823156 A1 WO9823156 A1 WO 9823156A1
Authority
WO
WIPO (PCT)
Prior art keywords
phenyl
pyridinyl
ocf
dime
naphthalenyl
Prior art date
Application number
PCT/US1997/021944
Other languages
English (en)
Inventor
Richard James Brown
Peter Paul Castro
Dominic Ming-Tak Chan
John Powell Daub
Gerard Michael Koether
Thomas Paul Selby
Paula Louise Sharpe
Original Assignee
E.I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/018916 external-priority patent/WO1998023155A1/fr
Application filed by E.I. Du Pont De Nemours And Company filed Critical E.I. Du Pont De Nemours And Company
Priority to EP97948597A priority Critical patent/EP0944314A1/fr
Priority to AU54633/98A priority patent/AU5463398A/en
Priority to JP52488998A priority patent/JP2001506984A/ja
Priority to BR9713415-5A priority patent/BR9713415A/pt
Publication of WO1998023156A1 publication Critical patent/WO1998023156A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Definitions

  • This invention relates to certain methyl substituted fungicides, their N-oxides, agriculturally suitable salts and compositions, and methods of their use as fungicides and arthropodicides.
  • the control of plant diseases caused by fungal plant pathogens is extremely important in achieving high crop efficiency. Plant disease damage to ornamental, vegetable, field, cereal, and fruit crops can cause significant reduction in productivity and thereby result in increased costs to the consumers.
  • the control of arthropod pests is also extremely important in achieving high crop efficiency. Arthropod damage to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer.
  • the control of arthropod pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health is also important. Many products are commercially available for these purposes, but the need continues for new compounds which are more effective, less costly, less toxic, environmentally safer or have different modes of action.
  • X is OR 1 , SCOJ ⁇ J R 1 or halogen;
  • A is O, S, N, NR 5 or CR 7 ;
  • G is C or N; provided that when G is C, A is O, S or NR 5 and the floating double bond is attached to G; and when G is N, A is N or CR 7 and the floating double bond is attached to A;
  • W is O; S; NH; N(C r C 6 alkyl); or NO(C r C 6 alkyl);
  • Y linkage is defined such that the moiety depicted on the left side of the linkage is bonded to the phenyl ring having the R 3 and R 4 substituents and the moiety on the right side of the linkage is bonded to Z;
  • Z is independently selected from: i) C]-C JO alkyl, CI -CJ Q haloalkyl or phenyl each optionally substituted with R 9 and optionally substituted with one or more R 10 ; ii) a ring selected from 5 or 6-membered aromatic heterocyclic ring, each heterocyclic ring containing 1 to 4 heteroatoms independently selected from the group nitrogen, oxygen, and sulfur, provided that each heterocyclic ring contains no more than 3 nitrogens, no more than 1 oxygen, and
  • R 7 is H, halogen or methyl
  • R 8 is H, C r C 3 alkyl, C r C 3 alkoxy, C r C 3 alkylthio, C r C 3 haloalkyl, C 2 -C 3 alkenyl,
  • R 9 is halogen; Ci-C alkyl; C j -Cg haloalkyl; C j -Cg alkoxy; C Cg haloalkoxy; C 2 -Cg alkenyl; C 2 -C 6 haloalkenyl; C 2 -Cg alkynyl; C j -Cg alkylthio;
  • R 12 is halogen, Cj-Cg alkyl, Cj-Cg haloalkyl, C j -C 6 alkoxy, C j -Cg haloalkoxy, C 2 -Cg alkenyl, C 2 -Cg haloalkenyl, C 2 -Cg alkynyl, C j -Cg alkylthio, C r C 6 haloalkylthio, C r C 6 alkylsulfinyl, C r C 6 alkylsulfonyl or C 3 -C 6 cycloalkyl;
  • R 13 is halogen, Cj-Cg alkyl, Cj-Cg haloalkyl, C j -Cg alkoxy, C j -Cg haloalkoxy or cyano; m is 0, 1 or 2; n is 0, 1 or 2; r is 1, 2, 3 or 4; and s is 0 or 1.
  • This invention provides a method for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidally effective amount of a compound of Formula I including all geometric and stereoisomers, N-oxide, and agriculturally suitable salts thereof, provided that when T is T 1 , then i) when Y is -O-, X is OMe, R 3 is CH 3 and R 4 is H, then Z is other than 6-chloro-4-pyrimidinyl and 6-chloro-2-pyrazinyl; ii) when Y is a direct bond, X is Cl, R 3 is CH 3 and R 4 is H, then Z is other than
  • This invention also provides selected compounds of Formula I which are considered particularly effective fungicides and arthropodicides. Specifically, this invention provides compounds of Formula I including all geometric and stereoisomers, N-oxides, and agriculturally suitable salts thereof, and agricultural compositions containing them and their use as fungicides and arthropodicides, provided that
  • R 10 other than methyl and halogen; and ix) when Y is -CH 2 O-, R 3 is CH 3 , Z is phenyl substituted with R 10 in the 2-position and R 10 is methyl or halogen, then Z is substituted with at least one
  • R 9 or R 10 other than methyl and halogen
  • haloalkylthio straight-chain or branched alkyl, such as, methyl, ethyl, r ⁇ -propyl, z ' -propyl, or the different butyl, pentyl or hexyl isomers.
  • alkyl used alone or in the compound word “haloalkyl” includes straight-chain or branched alkyl, such as, methyl, ethyl, «-propyl, z ' -propyl, or the different butyl, pentyl, hexyl, heptyl, octyl, nonyl and decyl isomers.
  • Alkenyl includes straight-chain or branched alkenes such as vinyl, 1-propenyl, 2-propenyl and the different butenyl, pentenyl and hexenyl isomers.
  • Alkenyl also includes polyenes such as 1 ,2-propadienyl and 2,4-hexadienyl.
  • Alkynyl includes straight-chain or branched alkynes such as ethynyl, 1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers.
  • Alkynyl can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl.
  • Alkoxy includes, for example, methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers.
  • Alkylthio includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers.
  • Alkylsulfinyl includes both enantiomers of an alkylsulfinyl group.
  • alkylsulfinyl examples include CH 3 S(O), CH 3 CH 2 S(O), CH 3 CH 2 CH 2 S(O), (CH 3 ) 2 CHS(O) and the different butylsulfinyl, pentylsulfinyl and hexylsulfinyl isomers.
  • alkylsulfonyl examples include CH 3 S(O) 2 , CH 3 CH 2 S(O) 2 , CH 3 CH 2 CH 2 S(O) 2 , (CH 3 ) 2 CHS(O) 2 and the different butylsulfonyl, pentylsulfonyl and hexylsulfonyl isomers.
  • Cycloalkyl includes, for example, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.
  • halogen either alone or in compound words such as “haloalkyl” includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of “haloalkyl” include F 3 C, C1CH 2 , CF 3 CH 2 and CF 3 CC1 2 .
  • haloalkenyl “haloalkynyl”, “haloalkoxy”, “haloalkylthio”, and the like, are defined analogously to the term “haloalkyl”.
  • haloalkynyl examples include HC ⁇ CCHCl, CF 3 C ⁇ C, CC1 3 C ⁇ C and FCH 2 C ⁇ CCH 2 .
  • haloalkoxy examples include CF 3 O, CCl 3 CH 2 O, HCF 2 CH 2 CH 2 O and CF 3 CH 2 O.
  • haloalkylthio examples include CC1 3 S, CF 3 S, CC1 3 CH 2 S and C1CH 2 CH 2 CH 2 S.
  • aromatic heterocyclic rings are defined as those rings which satisfy the H ⁇ ckel rule. Examples include: a 5- or 6- membered aromatic heterocyclic ring containing 1 to 4 heteroatoms such as furanyl, furazanyl, thienyl, pyrrolyl, pyrazolyl, oxazolyl, oxadiazolyl, imidazolyl, isoxazolyl, thiazolyl, thiadiazolyl isothiazolyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl and triazinyl with said ring attached through any available carbon or nitrogen.
  • the aromatic heterocyclic ring when the aromatic heterocyclic ring is furanyl, it can be 2-furanyl or 3-furanyl, for pyrrolyl, the aromatic heterocyclic ring is 1 -pyrrolyl, 2-pyrrolyl or 3-pyrrolyl, for pyridyl, the aromatic ring is 2-pyridyl, 3-pyridyl or 4-pyridyl and similarly for other aromatic heterocyclic rings.
  • the Y substituent is preferably attached to the aromatic ring of the tetrahydronaphthalene (i.e., the ring which satisfies the H ⁇ ckel rule).
  • Cj-C The total number of carbon atoms in a substituent group is indicated by the "Cj-C;" prefix where i and j are numbers from 1 to 10.
  • C j -C 3 alkylthio designates methylthio through propylthio.
  • alkylcarbonyl include C(O)CH 3 , C(O)CH 2 CH 2 CH 3 and C(O)CH(CH 3 ) 2 .
  • a group contains a substituent which can be hydrogen, for example R 2 or R 7 , then, when this substituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted.
  • a group is optionally substituted with a substituent, for example with R 1 , then, when the group is not substituted with that substituent, it is recognized that this is equivalent to said group having a hydrogen substituent.
  • Compounds of this invention can exist as one or more stereoisomers.
  • the various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers.
  • one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). (See, e.g., U.S. Provisional Patent Application Serial No.
  • the present invention comprises compounds selected from Formula I and agriculturally suitable salts thereof.
  • the compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.
  • the salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
  • inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
  • Preferred compounds for reasons of better activity and/or ease of synthesis are: Preferred 1.
  • Z is phenyl, pyridinyl, thiazolyl or thiadiazolyl, each optionally substituted with R 9 and optionally substituted with one or more R 10 ;
  • R 9 is halogen, C j -Cg alkyl, C j -Cg alkoxy, C j -Cg haloalkyl or C Cg haloalkoxy;
  • R 10 is halogen, C r C 6 alkyl, C r C 6 alkoxy, C r C 6 haloalkyl or
  • Z is phenyl, pyridinyl, thiazolyl or thiadiazolyl, each optionally substituted with R 9 and optionally substituted with one or more R 10 ;
  • R 9 is halogen, C j -Cg alkyl, C j -Cg alkoxy, C j -Cg haloalkyl or C j -Cg haloalkoxy;
  • R 10 is halogen, C r C 6 alkyl, C r C 6 alkoxy, C r C 6 haloalkyl or
  • G is N
  • Z is phenyl, pyridinyl, thiazolyl or thiadiazolyl, each optionally substituted with R 9 and optionally substituted with one or more R 10 ;
  • R 8 is CH 3 ;
  • R 9 is halogen, Cj-Cg alkyl, C j -Cg alkoxy, C j -Cg haloalkyl or
  • R 10 is halogen, C r C 6 alkyl, C r C 6 alkoxy, C r C 6 haloalkyl or Cj-Cg haloalkoxy; provided that i) when X is OMe, R 3 is CH 3 and R 4 is H, then Z is other than 3-(trifluoromethyl)phenyl; and ii) when X is OMe, R 3 is H and R 4 is CH 3 , then Z is other than 3-(trifluoromethyl)phenyl. Preferred 4.
  • T is T 1 ;
  • A is N;
  • G is N;
  • Z is thienyl optionally substituted with R 9 and optionally substituted with one or more R 10 ;
  • R 8 is CH 3 ;
  • R 9 is halogen or C ⁇ -C 3 alkyl; and R 10 is halogen or C r C 3 alkyl.
  • This invention also relates to fungicidal compositions comprising fungicidally effective amounts of the compounds of the invention and at least one of a surfactant, a solid diluent or a liquid diluent.
  • the preferred compositions of the present invention are those which comprise the above preferred compounds.
  • This invention also relates to a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, or to the plant seed or seedling, a fungicidally effective amount of the compounds of the invention (e.g., as a composition described herein).
  • the preferred methods of use are those involving the above preferred compounds.
  • This invention also relates to arthropodicidal compositions comprising arthropodicidally effective amounts of the compounds of the invention and at least one of a surfactant, a solid diluent or a liquid diluent.
  • This invention also relates to a method for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidally effective amount of the compounds of the invention (e.g., as a composition described herein).
  • the preferred methods of use are those involving the above preferred compounds.
  • T T 1
  • G G is N
  • A is N and the floating double bond is attached to A
  • W is O
  • X is OCH 3
  • R 8 is H, C r C 3 alkyl, C r C 3 haloalkyl, C 2 -C 3 alkenyl, C -C 3 alkynyl, cyclopropyl or cyano
  • Z is phenyl optionally substituted with R 9 and optionally substituted with R 10
  • R 9 is H, halogen, -C alkyl, C r C 6 haloalkyl, C j -Cg alkoxy, C r C 6 haloalkoxy, C -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C
  • R 9 is H, halogen, C j -C 6 alkyl, C j -Cg haloalkyl, Cj-Cg alkoxy, Cj-Cg haloalkoxy, C -C 6 alkenyl, C -Cg haloalkenyl, C 2 -C 6 alkynyl,
  • Compounds 1-10 and 40 in Index Table A are Compounds 1-10 and 40 in Index Table A. Also of note are compounds of Formula I other than Compounds 1-10 and 40 in Index Table A (e.g., Compounds 11-39 and 41-71 in Index Table A and Compound 72 in Index Table B).
  • the compounds of Formula I can be prepared by one or more of the following methods and variations as described in Schemes 1-46.
  • the definitions of T, A, G, W, X, Y, Z, R ⁇ -R 21 , m, n, r and s in the compounds of Formulae 1-62 below are as defined above in the Summary of the Invention.
  • Compounds of Formulae Ia-Iy are various subsets of the compounds of Formula I, and all substituents for Formulae Ia-Iy are as defined above for Formula I.
  • a compound of Formula I wherein T is T 1 and R 2 is H may exist as tautomer la or lb, or both la and lb.
  • Procedures 1) to 5 describe syntheses involving construction of the heterocycle after the formation of the aryl moiety.
  • Procedure 5) describes syntheses of the aryl moiety with the T-moiety already in place.
  • Suitable solvents are selected from the group consisting of polar aprotic solvents such as acetonitrile, dimethylformamide or dimethyl sulfoxide; ethers such as tetrahydrofuran, dimethoxyethane, or diethyl ether; ketones such as acetone or 2-butanone; hydrocarbons such as toluene or benzene; and halocarbons such as dichloromethane or chloroform.
  • polar aprotic solvents such as acetonitrile, dimethylformamide or dimethyl sulfoxide
  • ethers such as tetrahydrofuran, dimethoxyethane, or diethyl ether
  • ketones such as
  • Use of trimethylsilyldiazomethane requires a protic cosolvent such as methanol.
  • Suitable Lewis acids include trimethylsilyl triflate and tetrafluoroboric acid.
  • the alkyl trichloroacetimidates can be prepared from the appropriate alcohol and trichloroacetonitrile as described in the literature (J. Danklmaier and H. H ⁇ nig, Synth. Commun., (1990), 10, 203).
  • a trialkyloxonium tetrafluoroborate e.g., Meerwein's salt
  • the use of trialkyloxonium salts as powerful alkylating agents is well known in the art (see U. Sch ⁇ llkopf, U. Groth, C. O.ng, Angew. Chem., Int. Ed. Engl, (1981), 10, 798).
  • Appropriate bases include alkali metal alkoxides such as potassium tert-butoxide, inorganic bases such as sodium hydride and potassium carbonate, pyridine, or tertiary amines such as triethylamine, l,8-diazabicyclo[5.4.0]undec-7-ene (DBU), and triethylenediamine.
  • alkali metal alkoxides such as potassium tert-butoxide
  • inorganic bases such as sodium hydride and potassium carbonate
  • pyridine or tertiary amines such as triethylamine, l,8-diazabicyclo[5.4.0]undec-7-ene (DBU), and triethylenediamine.
  • the nucleophiles of Formula 6 are N-substituted hydroxylamines (HO- ⁇ HR 2 ) and substituted hydrazines (H ⁇ (R 5 )- ⁇ HR 2 ). Examples of such nucleophiles are N-methylhydroxylamine and methylhydrazine.
  • Compounds of Formula lb can be prepared by reaction of nitrile esters of Formula 7 with ambident nucleophiles of Formula 6. See M. Scobie and G. Tennant, J Chem. Soc, Chem. Comm., (1994), 2451. Alkylation of lb with alkyl halides in the presence of base provides compounds of Formula lc. Alternatively, treatment of lb with alkylamines or alkoxyamines provides compounds of Formula lc.
  • W N(C j -C alkyl) or NO(C j -Cg alkyl)
  • Esters of Formula 5a can be prepared from copper (I)-catalyzed reaction of malonate esters with substituted iodobenzenes of Formula 8 according to methods adapted from A. Osuka, T. Kobayashi and H. Suzuki, Synthesis , (1983), 67, and illustrated in Scheme 3.
  • R C j -C 4 alkyl
  • malonate esters of Formula 5a can be prepared by treating phenyl acetic acid esters of Formula 9a with a dialkyl carbonate or alkyl chloro formate in the presence of a suitable base such as, but not limited to, sodium metal and sodium hydride (Scheme 4).
  • a suitable base such as, but not limited to, sodium metal and sodium hydride (Scheme 4).
  • Nitrile esters of Formula 7 can be prepared similarly from compounds of Formula 10.
  • R C j -C 4 alkyl
  • Esters of Formula 9a (compounds of Formula 9 wherein E 1 is OR) can be prepared from acid-catalyzed alcoholysis of phenyl acetonitriles of Formula 10 or by esterification of phenyl acetic acids of Formula 11 as illustrated in Scheme 5 (see Org. Synth, Coll. Vol. I, (1941), 270).
  • Phenyl acetic acid esters of Formula 9b (compounds of Formula 9a wherein Y is Y 1 ) can also be prepared by copper (I)-catalyzed condensation of phenyl halides of Formula 12 with compounds of Formula 13 as described in EP-A-307,103 and illustrated below in Scheme 6.
  • Compounds of Formula 12 can be prepared by the Arndt-Eistert synthesis starting from benzoic acids of Formula 14 as illustrated in Scheme 7, (see F. Arndt, B. Eistert, Ber. 68, 200 (1935); T. Aoyama, T. Shioiri, Tetrahedron Letters 11, 4461 (1980)).
  • a halogenating agent such as thionyl chloride
  • an alkylating agent such as diazomethane
  • Compounds of Formula 14 can be prepared from nitrobenzoic acids of Formula 15 by a modification of the Sandmayer Reaction as taught in S. Kanoh, H. Muramoto, N. Kobayashi, M. Motoi and H. Suda, Bull. Chem. Soc. Jpn. 60, 3659 (1987) and M. P. Doyle, J Org. Chem. 41, 2426 (1977) (Scheme 8).
  • the compound can be prepared by nitration and reduction of commercially available 2,5-dimethylbenzoic acid as taught in A.N. Fugiwara, E. M. Acton, Can. J. Chem. 48, 1346 (1970).
  • esters of Formula 9c can also be prepared by forming the Y 2 bridge using conventional nucleophilic substitution chemistry (Scheme 9). Displacement of an appropriate leaving group (Lg) in electrophiles of Formula 17 or 18 with a nucleophilic ester of Formula 16 affords compounds of Formula 9c.
  • a base for example sodium hydride, is used to generate the corresponding alkoxide or thioalkoxide of the compound of Formula 16.
  • R C j -C 4 alkyl
  • Lg Br, Cl, I, OS0 2 CH 3 , OS0 2 (4-Me-Ph)
  • Compounds of Formula 16 can be prepared from compounds of Formula 12 by methods taught in Chem. Pharm. Bull 33 (12), 5184 (1985) or J. Org. Chem. 53 (2) 439, (1988). For example treatment of compounds of Formula 12 with a metal hydroxide, such as sodium hydroxide, in a polar protic solvent in the presence of a metal species such as copper yields compound 16a (compounds of Formula 16 where R 14 is OH).
  • Compounds of Formula 16b (compounds of Formula 16 where R 14 is CH 2 OH or CH 2 SH) can be prepared by metal-halogen exchange in compounds of Formula 12 followed by quenching with the appropriate electrophile.
  • reducing agents sodium borohydride (NaBH 4 ), sodium cyanoborohydride (NaCNBH 4 ) and diisobutylaluminum hydride (DIBAL-H) (Scheme 10).
  • Suitable inert solvents are methanol, ethanol, methylene chloride and THF, (see M. Hudlicky, Reductions in Organic Chemistry; John Wiley & Sons: New York, (1986)).
  • esters of Formula 9d can also be prepared by forming the Y 3 bridge from substituted hydroxylamines 16d and carbonyl compounds 19.
  • the hydroxylamines 16d are in turn prepared from esters 16c.
  • Compounds of Formula 16c where the Lg is Br, Cl, I, OSO 2 CH 3 or OSO 2 (4-Me-Ph) can be prepared from compounds of Formula 16b, (see March, J. Advanced Organic Chemistry, 3rd ed., John Wiley: New York, (1985). This method has been described in EP-A-600,835 and is illustrated in Scheme 11.
  • Compounds of Formula 20a can be prepared from compounds of Formula Id (compounds of Formula 1 wherein X 1 is OH) by reaction with halogenating agents such as thionyl chloride or phosphorus oxybromide to form the corresponding ⁇ -halo-substituted derivatives (Scheme 13).
  • halogenating agents such as thionyl chloride or phosphorus oxybromide
  • compounds of Formula Id can be treated with an alkylsulfonyl halide or haloalkylsulfonyl anhydride, such as methane sulfonyl chloride, />-toluenesulfonyl chloride, and trifluoromethanesulfonyl anhydride, to form the corresponding ⁇ -alkylsulfonate of Formula 20b.
  • the reaction with the sulfonyl halides may be performed in the presence of a suitable base (e.g., triethylamine).
  • sulfonyl compounds of Formula 20c can be prepared by oxidation of the corresponding thio compound of Formula 21 using well-known methods for the oxidation of sulfur (see Schrenk, K. in The Chemistry ofSulphones and Sulphoxides; Patai, S. et al., Eds.; Wiley: New York, (1988)).
  • Suitable oxidizing reagents include met ⁇ -chloro-peroxybenzoic acid, hydrogen peroxide and Oxone® (KHSO 5 ).
  • halo-compounds of Formula 20d can be prepared from hydrazides of Formula 22 as illustrated in Scheme 15.
  • the compound of Formula 22 is treated with excess of a thionyl halide such as thionyl chloride.
  • the product formed first is the ring-closed compound of Formula 23 which can be isolated or converted in situ to the compound of Formula 20d; see P. Molina, A. Tarraga, A. Espinosa, Synthesis, (1989), 923 for a description of this process.
  • the hydrazides of Formula 22 can be prepared as illustrated in Scheme 16. Condensation of the isocyanate of Formula 24 with the hydrazine of Formula H 2 NNR 2 R 15 in an inert solvent such as tetrahydrofuran affords the hydrazide.
  • R C j -C 4 alkyl 25a
  • Q 4 H, C j -Cg alkyl, C j -Cg alkoxy
  • the carbonylating agents can be alkyl chloroformates or dialkyl carbonates. Some of these carbonylating reactions may require the addition of a base to effect reaction.
  • Appropriate bases include alkali metal alkoxides such as potassium tert-butoxide, inorganic bases such as sodium hydride and potassium carbonate, pyridine, or tertiary amines such as triethylamine, l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) or triethylenediamine.
  • Suitable solvents include polar aprotic solvents such as acetonitrile, dimethylformamide, or dimethyl sulfoxide; ethers such as tetrahydrofuran, dimethoxyethane or diethyl ether; ketones such as acetone or 2-butanone; hydrocarbons such as toluene or benzene; or halocarbons such as dichloromethane or chloroform.
  • the reaction temperature can vary between 0 °C and 150 °C and the reaction time can be from 1 to 72 hours depending on the choice of base, solvent, temperature, and substrates.
  • Q 1 and Q 2 are independently Cl, OCCl 3 , 0(C j -C 4 alkyl), 1 -imidazolyl, 1,2,4-triazolyl
  • N-Amino-ureas of Formula 26 can be prepared as illustrated in Scheme 20.
  • Treatment of an aniline of Formula 27 with phosgene, thiophosgene, NN'-carbonyldiimidazole, or NN'-thiocarbonyldiimidazole produces the isocyanate or isothiocyanate of Formula 28.
  • a base can be added for reactions with phosgene or thiophosgene.
  • Subsequent treatment of the iso(thio)cyanate with an R 2 -substituted hydrazine produces the N-amino-urea of Formula 26.
  • Compounds of Formula 29 can be prepared by contacting benzyl halides, mesylates or tosylates of Formula 30 with various nucleophiles (Scheme 22).
  • the appropriate alcohol or thiol is treated with a base, for example sodium hydride, to form the corresponding alkoxide or thioalkoxide which acts as the nucleophile.
  • Lg Br, Cl, I, OS0 CH 3 , OS0 2 (4-Me-Ph)
  • Formula 30a (compounds of Formula 30 where the Lg group has been replaced with OH) by reaction with halogenating agents such as thionyl chloride or phosphorus oxybromide to form the corresponding ⁇ -halo-substituted derivatives (Scheme 23).
  • Compounds of Formula 30a can also be treated with an alkylsulfonyl halide or haloalkylsulfonyl anhydride, such as methane sulfonyl chloride, />-toluenesulfonyl chloride, and trifluoromethanesulfonyl anhydride, to form the corresponding ⁇ -alkylsulfonate of Formula 30.
  • the reaction with the sulfonyl halides may be performed in the presence of a suitable base (e.g., triethylamine).
  • Formula 1 f compounds can be prepared by reaction of Formula 28 iso(thio)cyanates or Formula 28a carbodiimides with Formula 35 esters. As described above, base may be added to accelerate the reaction and subsequent cyclization to Formula If compounds.
  • Carbodiimides 28a can be prepared as shown in Scheme 25, starting with compounds of Formula 28 and forming compounds of Formula 34 which are dehydrated to give compounds of Formula 28a.
  • the (thio)ureas or amidines of Formula 32 can be prepared by either of the methods illustrated in Scheme 26.
  • an iso(thio)cyanate of Formula 28 or carbodiimide of Formula 28a can be condensed with an amine of Formula R 2 -NH 2 to form the urea or amidine.
  • the anilines and iso(thio)cyanates of Formulae 27 and 28, respectively, are commercially available or prepared by well-known methods.
  • isothiocyanates can be prepared by methods described in J. Heterocycl. Chem. , (1990), 17, 407.
  • Isocyanates can be prepared as described in March, J. Advanced Organic Chemistry; 3rd ed., John Wiley: New York, (1985), pp 944, 1166.
  • Compounds of Formula Im (compounds of Formula I where T is T 1 , X is OR 1 , R 1 is CH 3 , R 2 is CH 3 , W is O, A is N, G is N, Y 5 is -O-, -OCH 2 - or -SCHR 1 ] -) can be prepared by forming the Y 5 bridge using conventional nucleophilic substitution chemistry (Scheme 30). Displacement of an appropriate leaving group (Lg) in electrophiles of Formula 17 or 18 with nucleophilic compounds of Formula 36 affords compounds of Formula Im.
  • a base for example sodium hydride, is used to generate the corresponding alkoxide or thioalkoxide of the compounds of Formula 37.
  • an additional substituent on Z which activates the leaving group (Lg) can be advantageous (e.g., when Lg-Z is 2-chloro-3 -nitro thiophene, the activating nitro group can be removed after coupling by reduction to the amine followed by diazotization and reduction to provide compounds of Formula Im).
  • Benzyl halides of Formula 38 can be prepared by radical halogenation of the corresponding alkyl compound of Formula 39a, see WO 96/38425. Benzyl halides can also be prepared by the acidic cleavage of the corresponding methyl ether of Formula 39b under conditions which provide the halide, see Scheme 31. Methods for preparing the corresponding compounds of Formula 38 wherein the T 1 group has been replaced by T 2 are described in WO 94/05620. Methods for preparing the corresponding compounds of Formula 38 wherein the T 1 group has been replaced by T 3 are described in EP-A-254,426, EP-A-299,694 and AU-A-55899/90.
  • compounds of Formula 38 can be prepared from the corresponding alcohol of Formula 40 by reaction with halogenating agents such as thionyl chloride or phosphorus oxybromide to form the corresponding ⁇ -halo-substituted derivatives.
  • compounds of Formula 40 can be treated with an alkylsulfonyl halide or haloalkylsulfonyl anhydride, such as methane sulfonyl chloride, / toluenesulfonyl chloride, and trifluoromethanesulfonyl anhydride, to form the corresponding ⁇ -alkylsulfonate of Formula 41.
  • the reaction with the sulfonyl halides may be performed in the presence of a suitable base (e.g., triethylamine) see Scheme 32.
  • Compounds of Formula 40 can be prepared by reducing esters of Formula 44 or aldehydes of Formula 43 with an appropriate reducing agent, (M. Hudlicky, Reductions in Organic Chemistry; John Wiley & Sons pp. 147-160, (1986)).
  • an appropriate reducing agent M. Hudlicky, Reductions in Organic Chemistry; John Wiley & Sons pp. 147-160, (1986)
  • DIBAL-H diisobutylaluminum hydride
  • Compounds of Formula 43 can be reduced with sodium borohydride in a protic solvent such as methanol or ethanol, Scheme 34.
  • Esters of Formula 44 can be prepared from anthranilic acid esters of Formula 45 according to the procedures described in Scheme 35.
  • Esters 45 can be prepared from readily accessible anthranilic acids by esterification techniques well known in the art.
  • a formaldehyde equivalent i.e., dimethylformamide or methyl chloro formate
  • compounds of Formula 48 can be prepared from compounds of Formula 46 by metallation using an alkyllithium followed by quenching with a trialkoxy borane, (Scheme 38), see Organic Synthesis via Boranes; Wiley: New York, (1975).
  • R Cj-C 4 alkyl
  • Compounds of Formula 54 are prepared by nitration of commercially available 2,5-dimethylphenol 53 as taught in M. Quertani, P. Girard and H. B. Kagan, Tetrahedron Letters, 13, 4315 (1982), Scheme 40.
  • R 0 P(CgH 5 ) 3 + (Cl. Br or l)
  • R 0 P(O(Cj-C4 alkyl)) 2
  • the olefin of Formula Ip can also be prepared by reversing the reactivity of the reactants in the Wittig or Horner-Emmons condensation.
  • 2-alkylphenyl derivatives of Formula 56 can be converted into the corresponding dibromo -compounds of Formula 57a as illustrated in Scheme 42 (see Synthesis, (1988), 330).
  • the dibromo- compounds can be hydrolyzed to the carbonyl compounds of Formula 57b, which in turn can be condensed with a phosphorus-containing nucleophile of Formula 58 or 59 to afford the olefins of Formula Ip.
  • NBS jV-bromosuccinimide 57b
  • Carbamates of Formula lu can be prepared by reacting benzyl alcohols of Formula 61 with iso(thio)cyanates of Formula 62 (Scheme 44).
  • a base such as triethylamine can be added to catalyze the reaction.
  • Compounds of Formula Iw may be prepared by methods described in EP-A- 178,826, EP-A-341,845 and EP-A-464,381.
  • a triarylbismuth compound or a substituted phenylboronic acid in the presence of cupric acetate and a tertiary amine such as pyridine or triethylamine as illustrated in Scheme 46.
  • organobismuth reagents in the preparation of diary 1 ethers is well known in the art (see Tetrahedron Lett., (1986), 17, 3619, and Tetrahedron Lett., (1987), 18, 887).
  • Boronic acids are well known in the literature (see Ada Chem. Scand. 1993, 47, 221 and references therein).
  • Step A Preparation of N-(2-methoxy-6-methylphenyl)-2,2- dimethylhvdrazinecarboxamide
  • phosgene 108 g, 1.09 moles
  • 2-methoxy-6-methylaniline 125.0 g, 911 mmol
  • Step B Preparation of 5-chloro-2.4-dihvdro-4-(2-methoxy-6-methylphenyl)-2- methyl-3H-l,2,4-triazol-3-one
  • the title compound of Step A (100.0 g, 447.9 mmol) was suspended in ethyl acetate (1 L) and added dropwise, via mechanical pump, over 3.5 h to a stirring solution of phosgene (177 g, 1.79 moles) in ethyl acetate (1.5 L) which was heated at reflux. After the addition was complete, the mixture was heated at reflux for a further 3 h, cooled to room temperature and stirred overnight.
  • Step D Preparation of 2.4-dihydro-4-(2-hvdroxy-6-methylphenyl)-5-methoxy-2- methyl-3H- 2.4-triazol-3-one
  • tetrahydrofuran 1.5 L
  • Step E Preparation of 2.4-dihydro-5-methoxy-2-methyl-4-[6-methyl-2-r3- ftrifluoromethyl phenoxy]phenyll-3H- 1.2.4-triazol-3-one
  • 2,4-dihydro-4-(2-hydroxy-6-methylphenyl)-5-methoxy-2-methyl-3H- l,2,4-triazol-3-one (0.50 g, 2.13 mmol)
  • methylene chloride 15 mL
  • Step B 2,4-dihydro-5-methoxy-2-methyl-4- 2-methyl-6-( ' 2-thienyloxy phenyll-3H-
  • 6-OCHF 2 -2-pyridinyl 3-Et-phenyl 1-naphthalenyl 1 ,2,3 ,4-tetrahydro-2-naphthalenyl
  • 6-(2,2,2-trifluoroethoxy)-4- 4-(2,2,2-trifluoroethoxy)-2- pyrimidinyl pyrimidinyl pyrimidinyl 3,5-diMe-phenyl 2-naphthalenyl 5,6,7,8-tetrahydro-2-naphthalenyl) 4-OCF 3 -phenyl 3-NBu-phenyl 4-/-Bu-phenyl 6-(2,2,2-trifluoroethoxy)-2- 3-SCF 3 -phenyl 4-SCF 3 -phenyl pyrazinyl 4-CF 3 -6-Me-2-pyridinyl 4 ,6-diMe-2-pyridiny 1 3,5-di(CF 3 )-phenyl 3-(CH 3 C ⁇ C)-phenyl Y -CH 2 0-
  • Y -OCH 2 - Z 2-Me-phenyl 2,5-diMe-phenyl 3-CF 3 -phenyl 4-CF -phenyl 4-Me-phenyl 4-?-Bu-phenyl 3-Cl-phenyl 4-Cl-phenyl 2-Me-5-Cl-phenyl 3-?-Bu-phenyl 2-naphthalenyl 1 -naphthalenyl 3 -pyridinyl 4-pyridinyl 6-Me-2-pyridinyl 5,6,7,8-tetrahydro-2-naphthalenyl
  • 6-(2,2,2-trifluoroethoxy)-4- 4-(2,2,2-trifluoroethoxy)-2- pyrimidinyl pyrimidinyl pyrimidinyl 3,5-diMe-phenyl 2-naphthalenyl 5,6,7, 8-tetrahydro-2-naphthalenyl) 4-OCF 3 -phenyl 3-Z-Bu-phenyl 4-/-Bu-phenyl 6-(2,2,2-trifluoroethoxy)-2- 3-SCF 3 -phenyl 4-SCF 3 -phenyl pyrazinyl 4-CF 3 -6-Me-2-pyridiny 1 4,6-diMe-2-pyridinyl 3,5-di(CF 3 )-phenyl 3-(CH 3 C ⁇ C)-phenyl Y -CH 2 0-
  • 6-(2,2,2-trifluoroethoxy)-4- 4-(2,2,2-trifluoroethoxy)-2- pyrimidinyl pyrimidinyl pyrimidinyl 3,5-diMe-phenyl 2-naphthalenyl 5,6,7,8-tetrahydro-2-naphthalenyl 4-OCF 3 -phenyl 3-t-Bu-phenyl 4-t-Bu-phenyl 6-(2,2,2-trifluoroethoxy)-2- 3-SCF 3 -phenyl 4-SCF 3 -phenyl pyrazinyl 4-CF3-6-Me-2 -pyridinyl 4,6-diMe-2-pyridinyl 3,5-di(CF 3 )-phenyl Y -CH 2 0-

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention concerne des composés de formule (I), ainsi que leurs N-oxydes et leurs sels adaptés à l'agriculture, qui sont utiles en tant que fongicides et arthropodicides. Dans la formule (I) T est représenté par (T?1), (T2), (T3) ou (T4); R3 et R4¿ représentent chacun indépendamment H ou CH¿3?, à condition que R?3 et R4¿ ne représentent pas tous les deux H; et A, G, W, X, Y, Z, R?1, R2, R5, R6¿ et s sont tels qu'ils sont définis dans l'invention. L'invention concerne également des compositions qui renferment les composés de formule (I), et un procédé pour lutter contre les maladies des plantes causées par les agents pathogènes de plantes fongiques, ce procédé impliquant l'application d'une quantité efficace d'un composé de formule (I). L'invention concerne enfin des compositions qui renferment les composés de formule (I) et un procédé pour lutter contre les arthropodes, ce procédé impliquant de mettre en présence les arthropodes ou leur environnement avec une quantité efficace d'un composé de formule (I).
PCT/US1997/021944 1996-11-26 1997-11-25 Fongicides et arthropodicides a substitution methyle WO1998023156A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP97948597A EP0944314A1 (fr) 1996-11-26 1997-11-25 Fongicides et arthropodicides a substitution methyle
AU54633/98A AU5463398A (en) 1996-11-26 1997-11-25 Methyl substituted fungicides and arthropodicides
JP52488998A JP2001506984A (ja) 1996-11-26 1997-11-25 メチル置換された殺菌・殺カビ剤および殺節足動物剤
BR9713415-5A BR9713415A (pt) 1996-11-26 1997-11-25 Método para controlar artrópodes, composto, composição fungicida, composição artropodicida e método para controlar doenças de plantas

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JPPCT/US96/18916 1996-11-26
PCT/US1996/018916 WO1998023155A1 (fr) 1996-11-26 1996-11-26 Amides cycliques arthropodicides et fongicides
US3361496P 1996-12-19 1996-12-19
US60/033,614 1996-12-19
US4884497P 1997-06-06 1997-06-06
US60/048,844 1997-06-06

Publications (1)

Publication Number Publication Date
WO1998023156A1 true WO1998023156A1 (fr) 1998-06-04

Family

ID=26709911

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/021944 WO1998023156A1 (fr) 1996-11-26 1997-11-25 Fongicides et arthropodicides a substitution methyle

Country Status (7)

Country Link
EP (1) EP0944314A1 (fr)
JP (1) JP2001506984A (fr)
KR (1) KR20000057254A (fr)
AU (1) AU5463398A (fr)
BR (1) BR9713415A (fr)
CZ (1) CZ184599A3 (fr)
WO (1) WO1998023156A1 (fr)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489487B1 (en) 1998-08-03 2002-12-03 Sumitomo Chemical Company, Limited Triazolone derivatives, use thereof, and intermediates therefor
US6824830B1 (en) * 1999-10-20 2004-11-30 Aventis Cropscience Gmbh Wood treatment
US7144888B2 (en) 2002-08-08 2006-12-05 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7301022B2 (en) 2005-02-15 2007-11-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7511044B2 (en) 2004-02-11 2009-03-31 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7534798B2 (en) 2004-02-11 2009-05-19 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US8722695B2 (en) 2009-12-11 2014-05-13 Autifony Therapeutics Limited Imidazolidinedione derivatives
WO2015056806A1 (fr) * 2013-10-17 2015-04-23 住友化学株式会社 Composé tétrazolinone et application associée
US9133175B2 (en) 2010-12-06 2015-09-15 Autifony Therapeutics Limited Compounds
US9193704B2 (en) 2011-06-07 2015-11-24 Autifony Therapeutics Limited Hydantoin derivatives as KV3 inhibitors
CN105636955A (zh) * 2013-10-17 2016-06-01 住友化学株式会社 四唑啉酮化合物及其用途
EP3047731A1 (fr) * 2015-01-21 2016-07-27 Basf Se Procédé de lutte contre la rouille du soja comprenant le traitement du soja avec des (2E)-2-[3-substitués-2 [[(E)-[(2E)-2-alkoxyimino-1-méthyl-2-phényl-ethylidene]amino]oxyméthyl]phényl]-2-méthoxy-imino-N-méthyl-acétamides
US9422252B2 (en) 2012-05-22 2016-08-23 Autifony Therapeutics Limited Triazoles as Kv3 inhibitors
US9512090B2 (en) 2013-07-31 2016-12-06 Sumitomo Chemical Company, Limited Tetrazolinone compound and use thereof
US9669030B2 (en) 2012-05-22 2017-06-06 Autifony Therapeutics Limited Hydantoin derivatives as Kv3 inhibitors
US9867372B2 (en) 2013-04-26 2018-01-16 Sumitomo Chemical Company, Limited Tetrazolinone compound and use of same
EP3903582A1 (fr) 2020-04-28 2021-11-03 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs qo ii
EP3903584A1 (fr) 2020-04-28 2021-11-03 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs qo iv
EP3903583A1 (fr) 2020-04-28 2021-11-03 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs qo iii
EP3903581A1 (fr) 2020-04-28 2021-11-03 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs i de qo
WO2021219390A1 (fr) 2020-04-28 2021-11-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acides aminés f129l dans la protéine cytochrome b mitochondrial conférant une résistance à des inhibiteurs iv de qo
WO2021219387A1 (fr) 2020-04-28 2021-11-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes contenant une substitution d'acides aminés f129l dans la protéine cytochrome b mitochondrial conférant une résistance à des inhibiteurs ii de qo
WO2021219388A1 (fr) 2020-04-28 2021-11-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acides aminés f129l dans la protéine cytochrome b mitochondrial conférant une résistance aux inhibiteurs iii de qo
WO2021219386A1 (fr) 2020-04-28 2021-11-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acides aminés f129l dans la protéine cytochrome b mitochondrial conférant une résistance aux inhibiteurs i de qo
EP3939961A1 (fr) 2020-07-16 2022-01-19 Basf Se Composés de type strobilurine et leur utilisation pour lutter contre les champignons phytopathogènes
WO2022033906A1 (fr) 2020-08-11 2022-02-17 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo viii
EP3970494A1 (fr) 2020-09-21 2022-03-23 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs qo viii
WO2023072671A1 (fr) 2021-10-28 2023-05-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo ix
WO2023072670A1 (fr) 2021-10-28 2023-05-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo x
WO2023072672A1 (fr) 2021-10-28 2023-05-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo xi
EP4361126A1 (fr) 2022-10-24 2024-05-01 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes contenant un f29l de substitution d'acide aminé

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001044215A2 (fr) * 1999-12-13 2001-06-21 Bayer Aktiengesellschaft Combinaisons fongicides de substances actives
JP6075182B2 (ja) * 2012-04-27 2017-02-08 住友化学株式会社 テトラゾリノン化合物及びその用途
WO2015119099A1 (fr) * 2014-02-05 2015-08-13 日本曹達株式会社 Composé de pyridine et son application
EP3670505A1 (fr) * 2018-12-18 2020-06-24 Bayer AG Pyridinyloxy-benzènes substituées ainsi que leurs sels et leur utilisation en tant que substances actives herbicides
JP2023025308A (ja) * 2020-01-31 2023-02-22 住友化学株式会社 ＱｏＩ殺菌剤に対して耐性を有するダイズさび病菌の防除方法

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178826A2 (fr) * 1984-10-19 1986-04-23 Zeneca Limited Fongicides
EP0226917A1 (fr) * 1985-12-20 1987-07-01 BASF Aktiengesellschaft Esters acryliques et fongicides contenant ces composés
EP0493711A1 (fr) * 1990-12-31 1992-07-08 BASF Aktiengesellschaft Procédé de préparation d'oximéthers d'esters de l'acide phénylglyoxylique
EP0517301A1 (fr) * 1991-06-05 1992-12-09 AgrEvo UK Limited Dérivés de l'acide propénique
WO1995014009A1 (fr) * 1993-11-19 1995-05-26 E.I. Du Pont De Nemours And Company Amides cycliques fongicides
WO1996017851A1 (fr) * 1994-12-08 1996-06-13 E.I. Du Pont De Nemours And Company Organosilanes et organogermanes arthropodicides et fongicides
WO1996026191A1 (fr) * 1995-02-24 1996-08-29 E.I. Du Pont De Nemours And Company Amides cycliques fongicides
WO1996036615A1 (fr) * 1995-05-16 1996-11-21 E.I. Du Pont De Nemours And Company Amides cycliques fongicides
WO1996038425A1 (fr) * 1995-05-29 1996-12-05 Sumitomo Chemical Company, Limited Derives de triazolone, leur utilisation, et intermediaires pour leur preparation
WO1997000612A1 (fr) * 1995-06-20 1997-01-09 E.I. Du Pont De Nemours And Company Amides cycliques arthropodicides et fongicides
WO1997005120A1 (fr) * 1995-07-26 1997-02-13 Sumitomo Chemical Company, Limited Derives de triazolone, utilisation de ces derives et d'intermediaires dans leur production

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178826A2 (fr) * 1984-10-19 1986-04-23 Zeneca Limited Fongicides
EP0226917A1 (fr) * 1985-12-20 1987-07-01 BASF Aktiengesellschaft Esters acryliques et fongicides contenant ces composés
EP0493711A1 (fr) * 1990-12-31 1992-07-08 BASF Aktiengesellschaft Procédé de préparation d'oximéthers d'esters de l'acide phénylglyoxylique
EP0517301A1 (fr) * 1991-06-05 1992-12-09 AgrEvo UK Limited Dérivés de l'acide propénique
WO1995014009A1 (fr) * 1993-11-19 1995-05-26 E.I. Du Pont De Nemours And Company Amides cycliques fongicides
WO1996017851A1 (fr) * 1994-12-08 1996-06-13 E.I. Du Pont De Nemours And Company Organosilanes et organogermanes arthropodicides et fongicides
WO1996026191A1 (fr) * 1995-02-24 1996-08-29 E.I. Du Pont De Nemours And Company Amides cycliques fongicides
WO1996036615A1 (fr) * 1995-05-16 1996-11-21 E.I. Du Pont De Nemours And Company Amides cycliques fongicides
WO1996038425A1 (fr) * 1995-05-29 1996-12-05 Sumitomo Chemical Company, Limited Derives de triazolone, leur utilisation, et intermediaires pour leur preparation
WO1997000612A1 (fr) * 1995-06-20 1997-01-09 E.I. Du Pont De Nemours And Company Amides cycliques arthropodicides et fongicides
WO1997005120A1 (fr) * 1995-07-26 1997-02-13 Sumitomo Chemical Company, Limited Derives de triazolone, utilisation de ces derives et d'intermediaires dans leur production

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489487B1 (en) 1998-08-03 2002-12-03 Sumitomo Chemical Company, Limited Triazolone derivatives, use thereof, and intermediates therefor
US6824830B1 (en) * 1999-10-20 2004-11-30 Aventis Cropscience Gmbh Wood treatment
US7144888B2 (en) 2002-08-08 2006-12-05 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7148221B2 (en) 2002-08-08 2006-12-12 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7332511B2 (en) 2002-08-08 2008-02-19 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7511044B2 (en) 2004-02-11 2009-03-31 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7534798B2 (en) 2004-02-11 2009-05-19 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US8227469B2 (en) 2004-02-11 2012-07-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7301022B2 (en) 2005-02-15 2007-11-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US9849131B2 (en) 2009-12-11 2017-12-26 Autifony Therapeutics Limited Imidazolidinedione derivatives
US10632118B2 (en) 2009-12-11 2020-04-28 Autifony Therapeutics Limited Imidazolidinedione derivatives
US8722695B2 (en) 2009-12-11 2014-05-13 Autifony Therapeutics Limited Imidazolidinedione derivatives
US10058551B2 (en) 2009-12-11 2018-08-28 Autifony Therapeutics Limited Imidazolidinedione derivatives
US9216967B2 (en) 2009-12-11 2015-12-22 Autifony Therapeutics Limited Imidazolidinedione derivatives
US11541052B2 (en) 2010-12-06 2023-01-03 Autifony Therapeutics Limited Compounds
US11197859B2 (en) 2010-12-06 2021-12-14 Autifony Therapeutics Limited Hydantoin derivatives useful as Kv3 inhibitors
US10098881B2 (en) 2010-12-06 2018-10-16 Autifony Therapeutics Limited Compounds
US9422272B2 (en) 2010-12-06 2016-08-23 Autifony Therapeutics Limited Compounds
US11583527B2 (en) 2010-12-06 2023-02-21 Autifony Therapeutics Limited Hydantoin derivatives useful as Kv3 inhibitors
US10555945B2 (en) 2010-12-06 2020-02-11 Autifony Therapeutics Limited Compounds
US10835534B2 (en) 2010-12-06 2020-11-17 Autifony Therapeutics Limited Compounds
US9133175B2 (en) 2010-12-06 2015-09-15 Autifony Therapeutics Limited Compounds
US9833452B2 (en) 2010-12-06 2017-12-05 Autifony Therapeutics Limited Compounds
US10265316B2 (en) 2010-12-06 2019-04-23 Autifony Therapeuctics Limited Hydantoin derivatives useful as Kv3 inhibitors
US9346790B2 (en) 2010-12-06 2016-05-24 Autifony Therapeutics Limited Hydantoin derivatives useful as Kv3 inhibitors
US9193704B2 (en) 2011-06-07 2015-11-24 Autifony Therapeutics Limited Hydantoin derivatives as KV3 inhibitors
US9422252B2 (en) 2012-05-22 2016-08-23 Autifony Therapeutics Limited Triazoles as Kv3 inhibitors
US10611735B2 (en) 2012-05-22 2020-04-07 Autifony Therapeutics Limited Triazoles as Kv3 inhibitors
US9669030B2 (en) 2012-05-22 2017-06-06 Autifony Therapeutics Limited Hydantoin derivatives as Kv3 inhibitors
US11180461B2 (en) 2012-05-22 2021-11-23 Autifony Therapeutics Limited Triazoles as Kv3 inhibitors
US10160730B2 (en) 2012-05-22 2018-12-25 Autifony Therapeutics Limited Triazoles as KV3 inhibitors
US9867372B2 (en) 2013-04-26 2018-01-16 Sumitomo Chemical Company, Limited Tetrazolinone compound and use of same
US9512090B2 (en) 2013-07-31 2016-12-06 Sumitomo Chemical Company, Limited Tetrazolinone compound and use thereof
US10077254B2 (en) 2013-10-17 2018-09-18 Sumitomo Chemical Company, Limited Tetrazolinone compound and use thereof
CN105636957B (zh) * 2013-10-17 2018-05-11 住友化学株式会社 四唑啉酮化合物及其用途
CN105636955B (zh) * 2013-10-17 2018-01-12 住友化学株式会社 四唑啉酮化合物及其用途
JPWO2015056806A1 (ja) * 2013-10-17 2017-03-09 住友化学株式会社 テトラゾリノン化合物及びその用途
WO2015056806A1 (fr) * 2013-10-17 2015-04-23 住友化学株式会社 Composé tétrazolinone et application associée
CN105636955A (zh) * 2013-10-17 2016-06-01 住友化学株式会社 四唑啉酮化合物及其用途
US10085450B2 (en) 2013-10-17 2018-10-02 Sumitomo Chemical Company, Limited Tetrazolinone compound and use thereof
CN105636957A (zh) * 2013-10-17 2016-06-01 住友化学株式会社 四唑啉酮化合物及其用途
EP3047731A1 (fr) * 2015-01-21 2016-07-27 Basf Se Procédé de lutte contre la rouille du soja comprenant le traitement du soja avec des (2E)-2-[3-substitués-2 [[(E)-[(2E)-2-alkoxyimino-1-méthyl-2-phényl-ethylidene]amino]oxyméthyl]phényl]-2-méthoxy-imino-N-méthyl-acétamides
CN115484821A (zh) * 2020-04-28 2022-12-16 巴斯夫欧洲公司 嗜球果伞素类型化合物防除在线粒体细胞色素b蛋白中含有赋予对Qo抑制剂III的耐受性的氨基酸替代F129L的植物病原性真菌的用途
CN115484820A (zh) * 2020-04-28 2022-12-16 巴斯夫欧洲公司 嗜球果伞素类型化合物防除在线粒体细胞色素b蛋白中含有赋予对Qo抑制剂I的耐受性的氨基酸替代F129L的植物病原性真菌的用途
WO2021219388A1 (fr) 2020-04-28 2021-11-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acides aminés f129l dans la protéine cytochrome b mitochondrial conférant une résistance aux inhibiteurs iii de qo
WO2021219386A1 (fr) 2020-04-28 2021-11-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acides aminés f129l dans la protéine cytochrome b mitochondrial conférant une résistance aux inhibiteurs i de qo
WO2021219390A1 (fr) 2020-04-28 2021-11-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acides aminés f129l dans la protéine cytochrome b mitochondrial conférant une résistance à des inhibiteurs iv de qo
EP3903581A1 (fr) 2020-04-28 2021-11-03 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs i de qo
WO2021219387A1 (fr) 2020-04-28 2021-11-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes contenant une substitution d'acides aminés f129l dans la protéine cytochrome b mitochondrial conférant une résistance à des inhibiteurs ii de qo
EP3903582A1 (fr) 2020-04-28 2021-11-03 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs qo ii
EP3903584A1 (fr) 2020-04-28 2021-11-03 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs qo iv
EP3903583A1 (fr) 2020-04-28 2021-11-03 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs qo iii
CN115460919A (zh) * 2020-04-28 2022-12-09 巴斯夫欧洲公司 嗜球果伞素类型化合物防除在线粒体细胞色素b蛋白中含有赋予对Qo抑制剂IV的耐受性的氨基酸替代F129L的植物病原性真菌的用途
CN115460920A (zh) * 2020-04-28 2022-12-09 巴斯夫欧洲公司 嗜球果伞素类型化合物防除在线粒体细胞色素b蛋白中含有赋予对Qo抑制剂II的耐受性的氨基酸替代F129L的植物病原性真菌的用途
EP3939961A1 (fr) 2020-07-16 2022-01-19 Basf Se Composés de type strobilurine et leur utilisation pour lutter contre les champignons phytopathogènes
WO2022013009A1 (fr) 2020-07-16 2022-01-20 Basf Se Composés de type strobilurine et leurs utilisations dans la lutte contre des champignons phytopathogènes
WO2022033906A1 (fr) 2020-08-11 2022-02-17 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo viii
EP3970494A1 (fr) 2020-09-21 2022-03-23 Basf Se Utilisation de composés de type strobilurine pour lutter contre les champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine mitochondriale du cytochrome b conférant une résistance aux inhibiteurs qo viii
WO2023072671A1 (fr) 2021-10-28 2023-05-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo ix
WO2023072670A1 (fr) 2021-10-28 2023-05-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo x
WO2023072672A1 (fr) 2021-10-28 2023-05-04 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes, contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo xi
EP4361126A1 (fr) 2022-10-24 2024-05-01 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes contenant un f29l de substitution d'acide aminé
WO2024088792A1 (fr) 2022-10-24 2024-05-02 Basf Se Utilisation de composés de type strobilurine pour lutter contre des champignons phytopathogènes contenant une substitution d'acide aminé f129l dans la protéine cytochrome b mitochondriale conférant une résistance à des inhibiteurs qo xv

Also Published As

Publication number Publication date
EP0944314A1 (fr) 1999-09-29
BR9713415A (pt) 2000-04-18
AU5463398A (en) 1998-06-22
JP2001506984A (ja) 2001-05-29
KR20000057254A (ko) 2000-09-15
CZ184599A3 (cs) 1999-09-15

Similar Documents

Publication Publication Date Title
EP0944314A1 (fr) Fongicides et arthropodicides a substitution methyle
WO1997000612A1 (fr) Amides cycliques arthropodicides et fongicides
AU677448B2 (en) Fungicidal cyclic amides
WO1998023155A1 (fr) Amides cycliques arthropodicides et fongicides
WO1996036229A1 (fr) Amides cycliques fongicides
WO1995007278A1 (fr) Aminopyrimidines fongicides, acaricides et arthropodicides
WO1999031072A1 (fr) Arthropodicides et fongicides de cyclohexylamine
WO1995003306A1 (fr) Heterocycles azacycliques arthropodicides
EP0934283A2 (fr) Amides cycliques arthropodicides et fongicides
US5962436A (en) Fungicidal cyclic amides
WO1999028305A1 (fr) Amides cycliques fongicides
US5728693A (en) Arthropodicidal oxadiazine-thiadiazine-or triazine-carboxanilides
EP0630370A1 (fr) Oxazolidinones fongicides
WO1999011129A1 (fr) Compositions enantiomeriquement enrichies et leur utilisation pesticide
EP0869963A1 (fr) Organosilanes et organogermanes arthropodicides et fongicides
US5633271A (en) Arthropodicidal oxazolines and thiazolines
WO1997011057A1 (fr) 1,4-dihydropyridines et 1,4-dihydropyrimidines arthropodicides
WO1998020003A1 (fr) Amides cycliques fongicides
WO1995019972A1 (fr) 2-oxa et thia-zolines arthropodicides
WO1999018102A1 (fr) Amides cycliques fongicides et arthropodicides
EP0821677A1 (fr) Arthropodicides d'oxazoline et de thiazoline
WO1997013773A1 (fr) Oxazolines et thiazolines arthropodicides
WO1994008976A1 (fr) Aminopyrimidines fongicides et acaricides
EP0804426A2 (fr) Oxazines et thiazines arthropodicides
MXPA99001173A (en) Arthropodicidal and fungicidal cyclic amides

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97180066.9

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE HU ID IL IS JP KG KP KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997948597

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 335918

Country of ref document: NZ

Ref document number: PA/A/1999/004789

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 1998 524889

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV1999-1845

Country of ref document: CZ

Ref document number: 09308751

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1019997004639

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: PV1999-1845

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1997948597

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019997004639

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV1999-1845

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1997948597

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1019997004639

Country of ref document: KR